A device that delivers a tyrosine kinase inhibitor can improve visual acuity and central subfield thickness in patients with diabetic macular edema, a 16-week phase 2 trial shows. Patients with ...
Researchers Jennifer Loh, MD, of Loh Ophthalmology Associates in Glenvar Heights, Florida, and Preeya Gupta, MD, of Triangle Eye Associates in Raleigh, North Carolina evaluated 613 patients between 45 ...
Belite Bio, Inc. ( NASDAQ: BLTE) Q3 2024 Earnings Conference Call November 12, 2024 4:30 PM ET Tom Lin - Chairman and Chief Executive Officer Hendrik Scholl - Chief Medical Officer Nathan Mata - Chief ...